Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden

Claudia Monaco1, Elisabetta Rossi, Diego Milazzo

  • 1Cytokine Biology of Vessels, Kennedy Institute of Rheumatology and Surgery, Anesthetics and Intensive Care, Faculty of Medicine, Imperial College, London, United Kingdom.

Insights

Systemic inflammation and atherosclerosis markers differed between unstable angina and peripheral artery disease patients. Atherothrombosis alone may not explain persistent unstable angina, suggesting a need to explore inflammatory mechanisms for new treatments.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Thrombosis Biology

Background:

  • Persistent unstable angina (UA) is frequently linked to coronary thrombosis and ongoing systemic inflammation.
  • Understanding the interplay between inflammation and atherothrombosis is crucial for managing cardiovascular events.

Purpose of the Study:

  • To investigate the relationship between systemic inflammation, atherosclerosis extent, and thrombosis markers.
  • To compare these markers in two distinct atherothrombosis clinical models: persisting UA and peripheral artery disease.

Main Methods:

  • Circulating markers of thrombotic and fibrinolytic cascades were assessed.
  • Soluble and cellular markers of systemic inflammation were measured on admission.
  • Patients with persisting UA (n=40) and peripheral artery disease (n=30) were analyzed.

Main Results:

  • Peripheral artery disease patients showed greater atherosclerosis extent and coagulation activation (thrombin-antithrombin III, D-dimer).
  • Unstable angina patients exhibited higher C-reactive protein, interleukin-6, and neutrophil activation markers.
  • These distinct inflammatory and thrombotic profiles persisted during hospitalization.

Conclusions:

  • A significant discrepancy exists between atherothrombotic burden and systemic inflammation in these models.
  • Atherothrombosis alone is unlikely to cause persistent, recurrent unstable angina.
  • Further research into inflammatory mechanisms is needed for novel therapeutic strategies in coronary instability.
Abstract

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...